Wealthspire Advisors (New York)’s Cardiol Therapeutics CRDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.6K Hold
15,151
﹤0.01% 843
2025
Q1
$14.7K Hold
15,151
﹤0.01% 785
2024
Q4
$19.4K Sell
15,151
-15,151
-50% -$19.4K ﹤0.01% 789
2024
Q3
$60K Buy
+30,302
New +$60K ﹤0.01% 737